DR. TAZEEN REHMAN M.D. NPI 1427241132

NPI Information

  • NPI: 1427241132
  • Provider Name: DR. TAZEEN REHMAN, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1220B E JOPPA RD
    SUITE 310
    BALTIMORE, MD
    ZIP 21286
  • Phone: (410) 494-1888

Map and Directions

Get Directions

NPI Details

DR. Tazeen Rehman, M.D. is a rheumatology internal medicine in Baltimore, MD with 24 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Tazeen Rehman, M.D. NPI is 1427241132. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

1220B E JOPPA RD
SUITE 310
BALTIMORE, MD
ZIP 21286-813
Phone: (410) 494-1888
Fax: (410) 494-1008

The NPI 1427241132 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Uric acid level, blood (HCPCS:84550)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)

The enumeration date for this NPI number is 8/26/2007 and was last updated on 9/4/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal MedicineP21915MARYLANDNo
2207RR0500XInternal MedicineRheumatologyD0068650MARYLANDYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.